DIVISLAB.NS Balance Sheet
Divi's Laboratories Ltd.
Profit & Loss Balance Sheet Cash Flow
Balance Sheet · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 21:45
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Property, Plant and Equipment | ₹47.14 Bn | ₹47.33 Bn | ₹54.37 Bn | ₹65.15 Bn | PropertyPlantAndEquipment |
| Capital Work-in-Progress | ₹2.12 Bn | ₹7.78 Bn | ₹10.22 Bn | ₹21.13 Bn | CapitalWorkInProgress |
| Goodwill | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | Goodwill |
| Other Intangible Assets | ₹0.08 Bn | ₹0.06 Bn | ₹0.04 Bn | ₹0.13 Bn | OtherIntangibleAssets |
| Non-current Investments | ₹0.77 Bn | ₹0.82 Bn | ₹0.65 Bn | ₹0.69 Bn | NoncurrentInvestments |
| Other Non-current Assets | ₹0.50 Bn | ₹1.30 Bn | ₹2.50 Bn | ₹1.46 Bn | OtherNoncurrentAssets |
| Total Non-current Assets | ₹51.27 Bn | ₹57.95 Bn | ₹68.51 Bn | ₹89.37 Bn | NoncurrentAssets |
| Inventories | ₹30.00 Bn | ₹31.84 Bn | ₹32.36 Bn | ₹39.54 Bn | Inventories |
| Trade Receivables | ₹17.93 Bn | ₹21.56 Bn | ₹27.31 Bn | ₹29.84 Bn | TradeReceivablesCurrent |
| Cash and Cash Equivalents | ₹1.70 Bn | ₹3.63 Bn | ₹4.15 Bn | ₹1.28 Bn | CashAndCashEquivalents |
| Current Investments | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | CurrentInvestments |
| Other Current Assets | ₹3.00 Bn | ₹3.48 Bn | ₹3.83 Bn | ₹7.36 Bn | OtherCurrentAssets |
| Total Current Assets | ₹93.12 Bn | ₹96.75 Bn | ₹100.81 Bn | ₹110.96 Bn | CurrentAssets |
| Total Assets | ₹144.39 Bn | ₹154.70 Bn | ₹169.32 Bn | ₹200.33 Bn | Assets |
| Equity Share Capital | ₹0.53 Bn | ₹0.53 Bn | ₹0.53 Bn | ₹0.53 Bn | EquityShareCapital |
| Other Equity | ₹127.14 Bn | ₹135.18 Bn | ₹149.16 Bn | ₹167.08 Bn | OtherEquity |
| Equity Attributable to Owners | ₹127.67 Bn | ₹135.71 Bn | ₹149.69 Bn | ₹167.61 Bn | EquityAttributableToOwnersOfParent |
| Non-controlling Interests | N/A | N/A | N/A | N/A | NonControllingInterest |
| Total Equity | ₹127.67 Bn | ₹135.71 Bn | ₹149.69 Bn | ₹167.61 Bn | Equity |
| Long-term Borrowings | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | BorrowingsNoncurrent |
| Total Non-current Liabilities | ₹5.71 Bn | ₹6.21 Bn | ₹5.11 Bn | ₹12.29 Bn | NoncurrentLiabilities |
| Short-term Borrowings | ₹0.00 Bn | ₹0.00 Bn | ₹0.02 Bn | ₹0.00 Bn | BorrowingsCurrent |
| Trade Payables | ₹7.63 Bn | ₹8.24 Bn | ₹9.10 Bn | ₹12.11 Bn | TradePayablesCurrent |
| Other Current Liabilities | ₹2.88 Bn | ₹3.03 Bn | ₹3.52 Bn | ₹2.98 Bn | OtherCurrentLiabilities |
| Total Current Liabilities | ₹11.01 Bn | ₹12.78 Bn | ₹14.52 Bn | ₹20.43 Bn | CurrentLiabilities |
| Total Equity and Liabilities | ₹144.39 Bn | ₹154.70 Bn | ₹169.32 Bn | ₹200.33 Bn | EquityAndLiabilities |
Every figure above is the exact value of the named XBRL element from DIVISLAB.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).